Disrupting & Redefining
Genetic Diagnostics
& Drug Discovery
functional and clinical impact
of all gene mutations

Heligenics believes that people can live healthier lives. We recognize major healthcare problems can be solved through advanced analysis of the function of genetic variation.

Do you want to modernize and improve healthcare with us?

Heligenics analyzes a gene mutation library (GML) with the GigaAssay™ to produce a comprehensive mutation effect on gene activity map (MEGA-Map™)

Problem

The function of most amino acid substitutions is largely unknown. The functional and clinical effect of almost all genetics changes remains unknown.

Current Approach

Companies identify variants through clinical associations with disease or drug therapy. Low throughput approaches are used to validate variants.

Our Solution

Heligenics solves this problem by experimentally measuring the impact of huge numbers of genetic changes at one time with its GigaAssay™ technology.
We also use our technology to create new biologics and for companion diagnostics.

Solutions to help...

Pharma/Biotechnology

Clinical Diagnostics

WHAT WE DO

At Heligenics, we believe that our solutions will soon become one of the biggest segments in the industry. We’ve only just started, but we already know that every product we build requires hard-earned skills, dedication and a daring attitude. Continue reading and learn about our revolutionary technology and its applications.

"Directly testing cell & molecular functions is the key to pathology and drug discovery"

Martin Schiller, CEO; Heligenics

Join the functional genome revolution!
Reach out today for more information.

CALL TO ACTION

Disrupting & Redefining Genetic Diagnostics & Drug Discovery functional and clinical impact of all gene mutations

Heligenics analyzes a gene mutation library (GML) with the GigaAssay™ to produce a comprehensive mutation effect on gene activity map (MEGA-Map™)

Problem The function of most amino acid substitutions is largely unknown. The functional and clinical effect of almost all genetics changes remains unknown.

Current Approach Companies identify variants through clinical associations with disease or drug therapy. Low throughput approaches are used to validate variants.

Our Solution Heligenics solves this problem by experimentally measuring the impact of huge numbers of genetic changes at one time with its GigaAssay™ technology. We also use our technology to create new biologics and for companion diagnostics.